Description:NebuSelect™ Recombinant Human LILRB2/CD85d/ILT4 Domain1&2, His-tag(Cat#NBL-242361) is expressed in HEK293 with His tag at the C-Terminus.It contains Gln22-Val229.

Species:Human

Expression System:HEK293

Molecular Weight: The protein has a predicted MW of 24.2 kDa. Due to glycosylation, the protein migrates to 25-30 kDa based on Bis-Tris PAGE result.

Target Name:LILRB2/CD85d/ILT4 Domain1&2SynonymsCD85d; ILT4; ILT-4; ILT4CD85d; LILRB2; LIR2; MIR10

Target Information:The immunoglobulin-like transcript (ILT) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIR). ILT4, also known as LIR-2 and LILRB2, is a type I transmembrane protein expressed primarily on monocytes and dendritic cells (DC). LILRB2 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles.

Purity:＞95%

Endotoxin:＜1EU/ug(LAL Method)